Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03211130 · ClinicalTrials.gov registry record · Early Phase 1
Using SystemCHANGE™ to Enhance Medication Adherence in Older Adult Stroke Survivors
A Early Phase 1 study, sponsored by University of Missouri, Kansas City.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT03211130 is a Early Phase 1 study that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 30 participants.
The verdict
NCT03211130, a Early Phase 1 study, has completed, sponsored by University of Missouri, Kansas City.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study evaluated the feasibility and acceptability of using a SystemCHANGE intervention in older adult stroke survivors to improve medication adherence. Half the participants will receive the SystemCHANGE intervention, while the other half will receive the attention-control education intervention.
Interventions
- BEHAVIORAL Attention-Control
- BEHAVIORAL SystemCHANGE™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-11-28 |
| Est. Completion | 2018-05-24 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03211130
The ClinicalTrials.gov registry entry for NCT03211130 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri, Kansas City, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention-Control is the first listed.
NCT03211130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03211130 about?
NCT03211130 is a clinical study titled "Using SystemCHANGE™ to Enhance Medication Adherence in Older Adult Stroke Survivors". This study evaluated the feasibility and acceptability of using a SystemCHANGE intervention in older adult stroke survivors to improve medication adherence. Half the participants will receive the SystemCHANGE intervention, while the other half will receive the attention-control education interventio...
What is the current status of trial NCT03211130?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2017-11-28. Estimated completion is 2018-05-24.
What interventions are being tested in trial NCT03211130?
The interventions under investigation include: Attention-Control (BEHAVIORAL), SystemCHANGE™ (BEHAVIORAL).
Who is sponsoring clinical trial NCT03211130?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.